Quality of life among inpatients with recurrent depressive disorder at the National Institute of Mental Health
Main Article Content
Abstract
Recurrent depressive disorder is a progressive mental disorder that causes many serious health problems as well as a huge disease burden. Patients with recurrent depression are predicted to have a reduced quality of life compared to the general population. The study was conducted on 109 inpatients with recurrent depressive disorder who were treated at the Institute of Mental Health - Bach Mai Hospital from January 2020 to December 2021. This is a case cluster analysis. The mean age was 48.67 ± 15.08 years old. The female: male ratio was approximately 2.6:1. At the time of admission, the mean quality of life score on the EQ5D scale of the study group was 0.55 ± 0.26. Statistically significant associations were found between quality of life among patients with recurrent depression at the time of hospitalization and two factors: anxiety symptom and pain symptom. The quality of life of patients after 2 weeks and after 4 weeks of treatment was statistically significantly higher than at the time of hospitalization.
Article Details
Keywords
Recurrent depressive disorder, quality of life, pain symptom, anxiety symptom
References
2. Hacker ED. Technology and Quality of Life Outcomes. Semin Oncol Nurs. 2010;26(1):47-58. doi:10.1016/j.soncn.2009.11.007
3. Bhatti SS, Tripathi NK, Nagai M, et al. Spatial Interrelationships of Quality of Life with Land Use/Land Cover, Demography and Urbanization. Soc Indic Res. 2017;132(3):1193-1216. doi:10.1007/s11205-016-1336-z
4. Otte C, Gold SM, Penninx BW, et al. Major depressive disorder. Nat Rev Dis Primer. 2016;2(1):1-20. doi:10.1038/nrdp.2016.65
5. Vos T, Barber RM, Bell B, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015;386(9995):743-800. doi:10.1016/S0140-6736(15)60692-4
6. Sadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. Wolters Kluwer Health; 2017.
7. Penninx BW, Milaneschi Y, Lamers F, et al. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med. 2013;11(1):129. doi:10.1186/1741-7015-11-129
8. Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: Past, Present and Future. Appl Health Econ Health Policy. 2017;15(2):127-137. doi:10.1007/s40258-017-0310-5
9. Seedat S, Scott KM, Angermeyer MC, et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry. 2009;66(7):785-795. doi:10.1001/archgenpsychiatry.2009.36
10. Kessing LV. Severity of depressive episodes during the course of depressive disorder. Br J Psychiatry. 2008;192(4):290-293. doi:10.1192/bjp.bp.107.038935
11. Cho Y, Lee JK, Kim DH, et al. Factors associated with quality of life in patients with depression: A nationwide population-based study. PLoS ONE. 2019;14(7):e0219455. doi:10.1371/journal.pone.0219455
12. Sapin C, Fantino B, Nowicki ML, et al. Usefulness of EQ-5D in Assessing Health Status in Primary Care Patients with Major Depressive Disorder. Health Qual Life Outcomes. 2004;2:20. doi:10.1186/1477-7525-2-20
13. Scott ES, Lubetkin EI, Janssen MF, et al. The performance relationship between the EQ-5D-5L composite “Anxiety/Depression” dimension and anxiety and depression symptoms in a large, general population sample. Qual Life Res. 2024;33(11):3107-3119. doi:10.1007/s11136-024-03754-5
14. Sobocki P, Ekman M, Agren H, et al. Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2007;10(2):153-160. doi:10.1111/j.1524-4733.2 006.00162.x